[HTML][HTML] Effect of sodium-glucose co-transporter 2 inhibitor, dapagliflozin, on renal renin-angiotensin system in an animal model of type 2 diabetes
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo, JW Kim… - PloS one, 2016 - journals.plos.org
Background Renal renin-angiotensin system (RAS) activation is one of the important
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
Effect of sodium-glucose co-transporter 2 inhibitor, dapagliflozin, on renal renin-angiotensin system in an animal model of type 2 diabetes
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo… - PLoS …, 2016 - cuk.elsevierpure.com
Background: Renal renin-angiotensin system (RAS) activation is one of the important
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo… - PLoS …, 2016 - search.ebscohost.com
Background: Renal renin-angiotensin system (RAS) activation is one of the important
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo, JW Kim… - Plos one, 2016 - europepmc.org
Background Renal renin-angiotensin system (RAS) activation is one of the important
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo, JW Kim… - PLoS ONE, 2016 - go.gale.com
Background Renal renin-angiotensin system (RAS) activation is one of the important
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
[引用][C] Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo… - PLoS …, 2016 - ui.adsabs.harvard.edu
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin
System in an Animal Model of Type 2 Diabetes - NASA/ADS Now on home page ads icon …
System in an Animal Model of Type 2 Diabetes - NASA/ADS Now on home page ads icon …
[HTML][HTML] Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo, JW Kim… - PLoS ONE, 2016 - ncbi.nlm.nih.gov
Background Renal renin-angiotensin system (RAS) activation is one of the important
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo… - PloS …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Renal renin-angiotensin system (RAS) activation is one of the important
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
[引用][C] Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo, JW Kim… - PLOS ONE, 2016 - cir.nii.ac.jp
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin
System in an Animal Model of Type 2 Diabetes | CiNii Research CiNii 国立情報学研究所 …
System in an Animal Model of Type 2 Diabetes | CiNii Research CiNii 国立情報学研究所 …
[PDF][PDF] Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
SJ Shin, S Chung, SJ Kim, EM Lee, YH Yoo… - PLoS …, 2016 - pdfs.semanticscholar.org
Background Renal renin-angiotensin system (RAS) activation is one of the important
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …
pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The …